Abstract
Purpose
To assess the optimal reporter probe/reporter gene combination for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene expression, we compared the cellular uptake of 1-(2′-fluoro-2′-deoxy-d-arabinofuranosyl)-5-methyluracil (FMAU), 2′-fluoro-2′-deoxyarabinofuranosyl-5-ethyluracil (FEAU), 2′-fluoro-2′-deoxy-β-d-arabinofuranosyl-5-iodouracil (FIAU) and penciclovir (PCV) in both HSV1-tk and HSV1-sr39tk expressing cells.
Procedures
For stably transfected cell studies, C6 rat glioma cells, C6 HSV1-tk transfectant, C6 mutant HSV1-sr39tk transfectant, rat Morris hepatoma cells (MH3924A), and MH3924A HSV1-tk transfectant cells were used. For adenoviral infection studies, C6 rat glioma cells were exposed to serial titers of AdCMV–HSV1-tk, AdCMV–HSV1-sr39tk, or AdCMV–fluc for 24 hours. These cells were incubated with [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV, and cellular uptake of radioactivity was measured.
Results
[3H]FEAU exhibited the highest or second highest accumulation and the most selectivity regardless of the mode of gene transfer for both HSV1-tk and mutant HSV1-sr39tk reporter genes.
Conclusion
This combination of high accumulation and high selectivity for both HSV1-tk and HSV1-sr39tk makes suitably radiolabeled FEAU a promising candidate as a radiotracer for imaging HSV1-tk/HSV1-sr39tk gene expression in living subjects.
Similar content being viewed by others
References
Deng WP, Yang WK, Lai WF, et al. (2004) Non-invasive in vivo imaging with radiolabeled FIAU For monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging 31:99–109
Tjuvajev JG, Stockhammer G, Desai R, Blasberg RG, et al. (1995) Imaging the expression of transfected genes in vivo. Cancer Res 55:6126–6132
Gambhir SS, Barrio JR, Wu L, et al. (1998) Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 39:2003–2011
Alauddin MM, Shahinian A, Kundu RK, Gordon EM, Conti PS (1999) Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol 26:371–376
Iyer M, Barrio JR, Namavari M, et al. (2001) 8-[18F]Fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 42:96–105
Alauddin MM, Shahinian A, Gordon EM, Bading JR, Conti PS (2001) Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J Nucl Med 42:1682–1690
Alauddin MM, Shahinian A, Gordon EM, Conti PS (2002) Evaluation of 2′-deoxy-2′-flouro-5-methyl-1-beta-d-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging 1:74–81
de Vries EFJ, van Waarde A, Harmsen MC, Mulder NH, Vaalburg W, Hospers GA (2000) [11C]FMAU and [18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl Med Biol 27:113–119
Iyer M, Bauer E, Barrio JR, et al. (2000) Comparison of FPCV, FHBG, and FIAU as reporter probes for imaging herpes simplex virus type 1 thymidine kinase reporter gene expression. J Nucl Med 41:80 pp (Abstract)
Tjuvajev J, Dubrovin M, Akhurst T, et al. (2001) Direct comparison of HSV1-TK PET imaging reporter probes: FIAU, FHPG, FHBG. J Nucl Med 42:277 pp (Abstract)
Brust P, Haubner R, Friedrich A, et al. (2001) Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur J Nucl Med 28:721–729
Wang HE, Deng WP, Chang PF, et al. (2002) Evaluation and comparison of 18F-FHBG and 131I-FIAU as gene probes in gene therapy. J Nucl Med 43:274 pp (Abstract)
Tjuvajev JG, Doubrovin M, Akhurst T, et al. (2002) Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 43:1072–1083
Buursma AR, Vaalburg W, Hospers GA, Mulder NH, de Vries EFJ (2003) Comparison of [18F]FHPG, [18F]FMAU, [18F]FLT and [18F]FEAU as radiotracers for herpes simplex virus thymidine kinase (HSVtk) gene expression. J Nucl Med 44:34 pp (Abstract)
Min JJ, Iyer M, Gambhir SS (2003) Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: Adenoviral infection vs. stable transfection. Eur J Nucl Med Mol Imaging 30:1547–1560
Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS (2004) Synthesis of 2′-deoxy-2′-[18F]fluoro-5-bromo-1-beta-d-arabinofuranosyluracil ([18F]-FBAU) and 2′-deoxy-2′-[18F]fluoro-5-chloro-1-beta-d-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol 31:399–405
Alauddin MM, Shahinian A, Gordon EM, Conti PS (2004) Direct Comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging 3:76–84
Alauddin MM, Conti PS (1998) Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): A new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 25:175–180
Gambhir SS, Bauer E, Black ME, et al. (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A 97:2785–2790
Bading JR, Shahinian AH, Bathija P, Conti PS (2000) Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-beta-d-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells. Nucl Med Biol 27:361–368
Wang H, Oliver P, Nan L, et al. (2002) Radiolabeled 2′-fluorodeoxyuracil-beta-d-arabinofuranoside (FAU) and 2′-fluoro-5-methyldeoxyuracil-beta-d-arabinofuranoside (FMAU) as tumor-imaging agents in mice. Cancer Chemother Pharmacol 49:419–424
Lu L, Samuelsson L, Bergstrom M, Sato K, Fasth KJ, Langstrom B (2002) Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers. J Nucl Med 43:1688–1698
Mangner TJ, Klecker RW, Anderson L, Shields AF (2003) Synthesis of 2′-deoxy-2′-[18F]fluoro-beta-d-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 30:215–224
Bading JR, Shahinian AH, Vail A, et al. (2004) Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol 31:407–418
Alauddin MM (2004) Synthesis of 2′-deoxy-2′-[18F]-fluoro-5-ethyl-1-β-d-arabinofuranosyluracil ([18F]-FEAU) and micro-PET imaging of suicide gene expression in tumor-bearing mice. J Nucl Med 45:448 pp (Abstract)
Haberkorn U, Altmann A, Morr I, et al. (1997) Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates. J Nucl Med 38:287–294
McLaren C, Chen MS, Ghazzouli I, Saral R, Burns WH (1985) Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir. Antimicrob Agents Chemother 28:740–744
Pankiewicz KW, Nawrot B, Gadler H, Price RW, Watanabe KA (1987) Nucleosides. 146. 1-Methyl-5-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)uracil, the C-nucleoside isostere of the potent antiviral agent 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)thymine (FMAU). Studies directed toward the synthesis of 2′-deoxy-2′-substituted arabino nucleosides. 6. J Med Chem 30:2314–2316
Abbruzzese JL, Schmidt S, Raber MN, et al. (1989) Phase I trial of 1-(2′-deoxy-2′-fluoro-1-beta-d-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity. Invest New Drugs 7:195–201
Cui L, Yoon S, Schinazi RF, Sommadossi JP (1995) Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-d-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest 95:555–563
Wang J, Eriksson S (1996) Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′-deoxy-2′-fluoro-1-beta-d-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob Agents Chemother 40:1555–1557
Morin KW, Duan W, Xu L, et al. (2004) Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells. Nucl Med Biol 31:623–630
Mansuri MM, Ghazzouli I, Chen MS, et al. (1987) 1-(2-Deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent. J Med Chem 30:867–871
Chou TC, Kong XB, Fanucchi MP, et al. (1987) Synthesis and biological effects of 2′-fluoro-5-ethyl-1-beta-d-arabinofuranosyluracil. Antimicrob Agents Chemother 31:1355–1358
Black ME, Newcomb TG, Wilson HM, Loeb LA (1996) Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A 93:3525–3529
Yaghoubi S, Barrio JR, Dahlbom M, et al. (2001) Human pharmacokinetic and dosimetry studies of [18F]FHBG: A reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42:1225–1234
Vries EF, Buursma AR, Hospers GA, Mulder NH, Vaalburg W (2002) Scintigraphic imaging of HSVtk gene therapy. Curr Pharm Des 8:1435–1450
Acknowledgment
We thank Dr. G. Sundaresan for technical assistance. This work funded in part by ICMIC P50 (SSG), and NIH R05 CA 082214 (SSG).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kang, K.W., Min, JJ., Chen, X. et al. Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for Monitoring Reporter Gene Expression of Wild Type and Mutant Herpes Simplex Virus Type 1 Thymidine Kinase in Cell Culture. Mol Imaging Biol 7, 296–303 (2005). https://doi.org/10.1007/s11307-005-0010-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-005-0010-7